Published in Oncogene on August 28, 2006
Integrated genomic characterization of papillary thyroid carcinoma. Cell (2014) 6.05
Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol Cell (2008) 2.70
Negative regulation of CHK2 activity by protein phosphatase 2A is modulated by DNA damage. Cell Cycle (2010) 2.12
The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev (2008) 2.06
Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst) (2009) 1.89
Overexpression of wip1 is associated with biologic behavior in human clear cell renal cell carcinoma. PLoS One (2014) 1.48
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas. Nat Genet (2014) 1.24
Regulation of the Wip1 phosphatase and its effects on the stress response. Front Biosci (Landmark Ed) (2012) 1.24
Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J (2009) 1.22
Mechanisms of checkpoint kinase Rad53 inactivation after a double-strand break in Saccharomyces cerevisiae. Mol Cell Biol (2007) 1.12
CHK2 kinase in the DNA damage response and beyond. J Mol Cell Biol (2014) 1.05
Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation. Cell Res (2009) 1.04
Phosphatases in the cellular response to DNA damage. Cell Commun Signal (2010) 0.97
The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair. DNA Repair (Amst) (2010) 0.96
Replication checkpoint: tuning and coordination of replication forks in s phase. Genes (Basel) (2013) 0.95
Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents. Proc Natl Acad Sci U S A (2011) 0.95
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. J Clin Oncol (2017) 0.92
Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1). Biochemistry (2011) 0.89
Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients. Br J Cancer (2015) 0.89
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity. Oncotarget (2016) 0.86
Interdependent phosphorylation within the kinase domain T-loop Regulates CHK2 activity. J Biol Chem (2010) 0.86
Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol. Mol Biol Rep (2013) 0.84
Wip1 phosphatase in breast cancer. Oncogene (2014) 0.83
A small molecular scaffold for selective inhibition of Wip1 phosphatase. ChemMedChem (2008) 0.81
Response to DNA damage: why do we need to focus on protein phosphatases? Front Oncol (2013) 0.81
Dynamics of DNA damage induced pathways to cancer. PLoS One (2013) 0.78
PP1α, PP1β and Wip-1 regulate H4S47 phosphorylation and deposition of histone H3 variant H3.3. Nucleic Acids Res (2013) 0.77
LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro. Cell Cycle (2016) 0.76
Recovery from the DNA Replication Checkpoint. Genes (Basel) (2016) 0.75
Centromeric DNA from Saccharomyces cerevisiae. J Mol Biol (1982) 9.64
Mitotic stability of yeast chromosomes: a colony color assay that measures nondisjunction and chromosome loss. Cell (1985) 8.78
S. cerevisiae 26S protease mutants arrest cell division in G2/metaphase. Nature (1993) 3.92
Socioeconomic, demographic, occupational, and health factors associated with participation in a long-term epidemiologic survey: a prospective study of the French GAZEL cohort and its target population. Am J Epidemiol (2001) 3.01
RPC40, a unique gene for a subunit shared between yeast RNA polymerases A and C. Cell (1987) 2.96
Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989. Am J Epidemiol (1994) 2.94
G1 cyclin turnover and nutrient uptake are controlled by a common pathway in yeast. Genes Dev (1995) 2.77
The SLT2(MPK1) MAP kinase is activated during periods of polarized cell growth in yeast. EMBO J (1996) 2.74
Cell cycle restriction of telomere elongation. Curr Biol (2000) 2.46
The SLT2 (MPK1) MAP kinase homolog is involved in polarized cell growth in Saccharomyces cerevisiae. J Cell Biol (1993) 2.31
Instability of dicentric plasmids in yeast. Proc Natl Acad Sci U S A (1983) 2.16
Civ1 (CAK in vivo), a novel Cdk-activating kinase. Cell (1996) 1.99
Structure and sequence of the centromeric DNA of chromosome 4 in Saccharomyces cerevisiae. Mol Cell Biol (1986) 1.95
Reversion of a promoter deletion in yeast. Nature (1982) 1.94
Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci U S A (1993) 1.91
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature (1989) 1.91
Regulation of cytokinesis by the Elm1 protein kinase in Saccharomyces cerevisiae. J Cell Sci (2000) 1.64
Sickness absence at the French National Electric and Gas Company. Br J Ind Med (1987) 1.62
Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particle. Trends Biochem Sci (1998) 1.55
Exposure to 50-Hz electric field and incidence of leukemia, brain tumors, and other cancers among French electric utility workers. Am J Epidemiol (1996) 1.54
CT guided diagnostic foot injections. Clin Radiol (2005) 1.50
Congestive cardiac manifestations from cerebrocranial arteriovenous shunts. Endovascular management in 30 children. Childs Nerv Syst (1991) 1.48
Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol (1994) 1.46
An overview of techniques for dealing with large numbers of independent variables in epidemiologic studies. Prev Vet Med (1997) 1.45
[Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?]. Gynecol Obstet Fertil (2005) 1.44
Comparison of four severity scores in patients with head trauma. J Trauma (1989) 1.44
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg (2000) 1.43
Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity. J Nucl Med (1995) 1.40
Complications in early diagnosis and treatment of two infants with long-chain fatty acid beta-oxidation defects. J Pediatr Gastroenterol Nutr (2000) 1.40
Women's health research blossoms. Science (1995) 1.39
Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT Trial. Rapid Early Action for Coronary Treatment. Coron Artery Dis (2000) 1.38
Suppression of nuclear oscillations in Saccharomyces cerevisiae expressing Glu tubulin. Proc Natl Acad Sci U S A (2004) 1.36
Meiotic disjunction of circular minichromosomes in yeast does not require DNA homology. Proc Natl Acad Sci U S A (1986) 1.35
Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients. Am J Trop Med Hyg (2001) 1.35
Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest (1994) 1.34
Diagnosis-specific sickness absence and all-cause mortality in the GAZEL study. J Epidemiol Community Health (2008) 1.32
Xbp1-mediated repression of CLB gene expression contributes to the modifications of yeast cell morphology and cell cycle seen during nitrogen-limited growth. Mol Cell Biol (2001) 1.31
Deletion of plasmid sequences during Saccharomyces cerevisiae transformation. J Bacteriol (1984) 1.25
Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol (1992) 1.20
Saccharomyces cerevisiae MPS2 encodes a membrane protein localized at the spindle pole body and the nuclear envelope. Mol Biol Cell (1999) 1.19
Management of subglottic foreign bodies. Ann Otol Rhinol Laryngol (1996) 1.16
G2 cyclins are required for the degradation of G1 cyclins in yeast. Nature (1996) 1.13
Silent repair accounts for cell cycle specificity in the signaling of oxidative DNA lesions. EMBO J (2001) 1.11
Sickness absence as a prognostic marker for common chronic conditions: analysis of mortality in the GAZEL study. Occup Environ Med (2008) 1.08
Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. Biochemistry (1995) 1.08
Genetic characterization of Toxoplasma gondii from wild boar (Sus scrofa) in France. Vet Parasitol (2009) 1.07
Meta-analysis in the breech. Science (1990) 1.05
Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites. Proc Natl Acad Sci U S A (1995) 1.04
Atrial natriuretic factor (ANF) is a potent bronchodilator in asthma. J Allergy Clin Immunol (1990) 1.03
Epidemiological survey of trichinellosis in wild boar (Sus scrofa) and fox (Vulpes vulpes) in a French insular region, Corsica. Vet Parasitol (2010) 1.02
The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells. Oncogene (2009) 1.01
DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors. Mutat Res (1995) 1.01
The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients. Br J Haematol (1985) 1.00
[G1 cyclin degradation and cell differentiation in Saccharomyces cerevisiae]. C R Acad Sci III (1995) 1.00
The epidemiological information system of the French national electricity and gas company: the SI-EPI project. Med Lav (1996) 1.00
Do orthopaedic surgeons need a policy on the removal of metalwork? A descriptive national survey of practicing surgeons in the United Kingdom. Injury (2008) 0.99
Sleep problems in children and their relationship with early disturbances of the waking-sleeping rhythms. Sleep (1983) 0.98
A yeast heat shock transcription factor (Hsf1) mutant is defective in both Hsc82/Hsp82 synthesis and spindle pole body duplication. J Cell Sci (1997) 0.98
Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre. Clin Exp Dermatol (2010) 0.98
A human IgG myeloma protein with anti- 2 macroglobulin antibody activity. J Immunol (1973) 0.98
Oxidative stress and the induction of cyclooxygenase enzymes and apoptosis in the murine placenta. Placenta (2007) 0.97
Functional expression of the human CHIP28 water channel in a yeast secretory mutant. FEBS Lett (1995) 0.97
Clinical diagnosis of acute coronary syndrome in patients with chest pain and a normal or non-diagnostic electrocardiogram. Emerg Med J (2009) 0.96
Biochemical and genetic dissection of the Saccharomyces cerevisiae RNA polymerase C53 subunit through the analysis of a mitochondrially mis-sorted mutant construct. J Biol Chem (1992) 0.95
T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia. Ann Immunol (Paris) (1975) 0.95
Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma. Eur J Nucl Med (1998) 0.94
Involvement of the PP2C-like phosphatase Ptc2p in the DNA checkpoint pathways of Saccharomyces cerevisiae. Genetics (2000) 0.93
eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabet Med (2002) 0.93
Sequence and functional expression of an amphibian water channel, FA-CHIP: a new member of the MIP family. Biochim Biophys Acta (1994) 0.92
Targeted surveillance to assess the prevalence of BSE in high-risk populations in western France and the associated risk factors. Vet Rec (2002) 0.92
Parallel pathways in RAF-induced senescence and conditions for its reversion. Oncogene (2011) 0.91
In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells. Exp Hematol (2000) 0.91
pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy. Cancer Res (1991) 0.91
Use of the patient at risk scores in the emergency department: a preliminary study. Emerg Med J (2004) 0.90
Specificity of Cdk activation in vivo by the two Caks Mcs6 and Csk1 in fission yeast. EMBO J (2001) 0.90
Occupational respiratory cancer and exposure to asbestos: a case-control study in a cohort of workers in the electricity and gas industry. Am J Ind Med (1995) 0.90
APRAND programme: an intervention to prevent relapses of anxiety and depressive disorders. First results of a medical health promotion intervention in a population of employees. Eur Psychiatry (2006) 0.90
Analysis of mucosal bladder leucocyte subpopulations in patients treated with intravesical Bacillus Calmette-Guerin. Urol Res (1989) 0.89
Multiple eruptive dermatofibromas in three men with HIV infection. Dermatology (1997) 0.89
Seroprevalence and factors associated with Toxoplasma gondii infection in wild boar ( Sus scrofa) in a Mediterranean island. Epidemiol Infect (2010) 0.89
Estimates of the prevalence of transmissible spongiform encephalopathies in sheep and goats in France in 2002. Vet Rec (2006) 0.89
Downregulation of aquaporin-2 and -3 in aging kidney is independent of V(2) vasopressin receptor. Am J Physiol Renal Physiol (2000) 0.88
Occupational risk factors for lung cancer in the French electricity and gas industry: a case-control survey nested in a cohort of active employees. Am J Epidemiol (2000) 0.88
Scintigraphic imaging of paediatric thyroid dysfunction. Horm Res (2008) 0.88
Ear clicks in palatal tremor caused by activity of the levator veli palatini. Neurology (1996) 0.88
An analysis of Hospital Discharge Index as a trauma data base. J Trauma (1995) 0.87
Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care (1998) 0.87
Monitoring of end-tidal carbon dioxide partial pressure changes during infrarenal aortic cross-clamping: a non-invasive method to predict unclamping hypotension. Acta Anaesthesiol Scand (2001) 0.87
The preoperative administration of ketoprofen improves analgesia after laparoscopic cholecystectomy in comparison with propacetamol or postoperative ketoprofen. Br J Anaesth (2004) 0.85
Patient-controlled epidural analgesia after abdominal surgery: ropivacaine versus bupivacaine. Anesth Analg (2001) 0.85
Urolithiasis in patients with end stage renal failure. J Urol (1992) 0.85
Chronic consumption of fresh but not heated yogurt improves breath-hydrogen status and short-chain fatty acid profiles: a controlled study in healthy men with or without lactose maldigestion. Am J Clin Nutr (2000) 0.84
Surgical staging of early invasive epithelial ovarian tumors. Semin Surg Oncol (2000) 0.84
Three-dimensional visualisation of the large bowel: a potential tool for assessing targeted drug delivery and colonic pathology. Eur J Nucl Med (1995) 0.84
Characterization of a monoclonal antibody recognizing a monomorphic determinant of the alpha chain of class II DQ antigens. Scand J Immunol (1986) 0.84
Aquaporin-2 downregulation in kidney medulla of aging rats is posttranscriptional and is abolished by water deprivation. Am J Physiol Renal Physiol (2008) 0.84
Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals. Cell Biol Toxicol (1992) 0.84
A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments. Br J Radiol (2005) 0.83
Two distinctly altered cellular responses to DNA double-strand breaks in human neuroblastoma. Biochimie (2008) 0.83
A fructose-rich diet decreases insulin-stimulated glucose incorporation into lipids but not glucose transport in adipocytes of normal and diabetic rats. J Nutr (1995) 0.83